home / stock / incr / incr news


INCR News and Press, Intercure Ltd. From 02/14/23

Stock Information

Company Name: Intercure Ltd.
Stock Symbol: INCR
Market: NASDAQ
Website: intercure.co

Menu

INCR INCR Quote INCR Short INCR News INCR Articles INCR Message Board
Get INCR Alerts

News, Short Squeeze, Breakout and More Instantly...

INCR - Daily Hit: February 14, 2023

The Daily Hit is a recap of the top financial news stories for February 14, 2023. On the Site Cannabis Consumers in the Mood for Love Cannabis consumers love to celebrate Valentine’s Day. Wholesale cannabis platform Leaflink reported an enormous increase in sales in the wee...

INCR - InterCure Sues Better Over Funds During Failed Merger

InterCure Ltd. (Nasdaq: INCR), also known as Canndoc, filed a lawsuit against Cann Pharmaceuticals Ltd., also known as Better, to recover some of the money that was loaned to and invested in the company when the two contemplated a merger. In the company’s earnings filing in Novem...

INCR - InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

NEW YORK, TORONTO, and HERZLIYA, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“ InterCure ” or the “ Company ”) the biggest and most profitable cannabis company outside of north America, announ...

INCR - InterCure Kills Deal With To Buy Better

InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) has killed its deal with Cann Pharmaceutical Ltd. dated as of February 13, 2022, to buy the company also known as Better. The company announced the acquisition was in trouble in November 2022 and cites fundamental disagreements between t...

INCR - InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

NEW YORK and TORONTO and HERZLIYA, Israel, Feb. 01, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Company ") announces that, further to the merger agreement with Cann Pharmaceutical Ltd. (“ Better ...

INCR - InterCure: Why The Company Is Grossly Undervalued By Wall Street

Summary InterCure earned CAD$39 million in Q3 2022, up 61.2% from the previous year. Moreover, at the end of Q4 2022, the total number of licensed patients using cannabis for medical purposes in Israel was 123,212, up 13,860 from the previous year. Currently, the cannabis industry c...

INCR - Cannabis Is A Long-Term Play (Podcast Transcript)

Summary Negative conditions are crashing down all around investors. Make sure companies in your portfolio will survive. Ted Waller shares why some stocks are falling off a cliff. Not all ETFs are created equal - stay away from the leveraged ETFs ('dynamite ready to be lit'). Pin...

INCR - Cannabis Is A Long-Term Play

Summary Negative conditions are crashing down all around investors. Make sure companies in your portfolio will survive. Ted Waller shares why some stocks are falling off a cliff. Not all ETFs are created equal - stay away from the leveraged ETFs ('dynamite ready to be lit'). Pin...

INCR - Investing In The New Cannabis World After A Terrible 2022

Summary A convergence of factors caused the poor performance of cannabis stocks in 2022. The investing environment has changed, and cannabis investors must change along with it. The potential for investor profits is as strong as ever, but investors must be strategically selective. ...

INCR - InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 19, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Compan y "), the largest and fastest growing medical cannabis company outside of North America, today an...

Previous 10 Next 10